| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 4.889 | 12.135 | 2.062 | 902 | 516 | 0 |
| Total Income - EUR | - | - | - | 6.501 | 15.187 | 22.299 | 6.641 | 5.496 | 5.105 | 4.554 |
| Total Expenses - EUR | - | - | - | 10.077 | 17.142 | 15.500 | 10.275 | 8.841 | 7.632 | 6.001 |
| Gross Profit/Loss - EUR | - | - | - | -3.576 | -1.955 | 6.799 | -3.633 | -3.345 | -2.527 | -1.447 |
| Net Profit/Loss - EUR | - | - | - | -3.577 | -2.004 | 6.634 | -3.695 | -3.372 | -2.527 | -1.447 |
| Employees | - | - | - | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Mora Biorezo Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 34.481 | 29.040 | 23.806 | 24.645 | 18.694 | 12.759 | 6.854 |
| Current Assets | - | - | - | 6.241 | 2.858 | 9.532 | 2.042 | 1.262 | 758 | 587 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 6.202 | 115 | 115 | 11 | 11 |
| Cash | - | - | - | 6.241 | 2.858 | 3.330 | 1.927 | 1.148 | 747 | 576 |
| Shareholders Funds | - | - | - | -3.534 | -5.470 | 1.268 | -2.455 | -5.835 | -8.344 | -9.745 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 10.409 | 8.950 | 8.875 | 11.040 | 12.228 | 12.918 | 12.846 |
| Income in Advance | - | - | - | 33.846 | 28.417 | 23.195 | 18.102 | 13.564 | 8.943 | 4.340 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Mora Biorezo Medical Srl